The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global Veterinary Vaccines market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Vaccines in various end use industries. The expanding demands from the Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute and Retail Pharmacy, are propelling Veterinary Vaccines market. Inactivated Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Attenuated Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 106%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Vaccines covered in this report include Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc.
The global Veterinary Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Global Veterinary Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Vaccines market, Segment by Type:
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Others
Global Veterinary Vaccines market, by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global Veterinary Vaccines market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Vaccines in various end use industries. The expanding demands from the Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute and Retail Pharmacy, are propelling Veterinary Vaccines market. Inactivated Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Attenuated Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 106%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Vaccines covered in this report include Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc.
The global Veterinary Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Global Veterinary Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Vaccines market, Segment by Type:
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Others
Global Veterinary Vaccines market, by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Veterinary Vaccines
1.1 Veterinary Vaccines Market Overview
1.1.1 Veterinary Vaccines Product Scope
1.1.2 Veterinary Vaccines Market Status and Outlook
1.2 Global Veterinary Vaccines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Vaccines Market Size by Region (2018-2029)
1.4 Global Veterinary Vaccines Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Vaccines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Vaccines Market Size (2018-2029)
1.6.1 North America Veterinary Vaccines Market Size (2018-2029)
1.6.2 Europe Veterinary Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Vaccines Market Size (2018-2029)
1.6.4 Latin America Veterinary Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Vaccines Market Size (2018-2029)
2 Veterinary Vaccines Market by Type
2.1 Introduction
2.1.1 Inactivated Vaccines
2.1.2 Live Attenuated Vaccines
2.1.3 Conjugate Vaccines
2.1.4 Toxoid Vaccines
2.1.5 Recombinant Vaccines
2.1.6 DNA Vaccines
2.1.7 Others
2.2 Global Veterinary Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Vaccines Historic Market Size by Type (2018-2023)
2.2.2 Global Veterinary Vaccines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
3 Veterinary Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Clinic
3.1.2 Veterinary Hospital
3.1.3 Veterinary Research Institute
3.1.4 Retail Pharmacy
3.1.5 Others
3.2 Global Veterinary Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Vaccines Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Vaccines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
4 Veterinary Vaccines Competition Analysis by Players
4.1 Global Veterinary Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2022)
4.3 Date of Key Players Enter into Veterinary Vaccines Market
4.4 Global Top Players Veterinary Vaccines Headquarters and Area Served
4.5 Key Players Veterinary Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Elanco
5.1.1 Elanco Profile
5.1.2 Elanco Main Business
5.1.3 Elanco Veterinary Vaccines Products, Services and Solutions
5.1.4 Elanco Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.1.5 Elanco Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Veterinary Vaccines Products, Services and Solutions
5.2.4 Merck Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Merial
5.3.1 Merial Profile
5.3.2 Merial Main Business
5.3.3 Merial Veterinary Vaccines Products, Services and Solutions
5.3.4 Merial Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.3.5 Zoetis Recent Developments
5.4 Zoetis
5.4.1 Zoetis Profile
5.4.2 Zoetis Main Business
5.4.3 Zoetis Veterinary Vaccines Products, Services and Solutions
5.4.4 Zoetis Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.4.5 Zoetis Recent Developments
5.5 Advaxis
5.5.1 Advaxis Profile
5.5.2 Advaxis Main Business
5.5.3 Advaxis Veterinary Vaccines Products, Services and Solutions
5.5.4 Advaxis Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.5.5 Advaxis Recent Developments
5.6 AmpliPhi Biosciences
5.6.1 AmpliPhi Biosciences Profile
5.6.2 AmpliPhi Biosciences Main Business
5.6.3 AmpliPhi Biosciences Veterinary Vaccines Products, Services and Solutions
5.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.6.5 AmpliPhi Biosciences Recent Developments
5.7 Aratana Therapeutics
5.7.1 Aratana Therapeutics Profile
5.7.2 Aratana Therapeutics Main Business
5.7.3 Aratana Therapeutics Veterinary Vaccines Products, Services and Solutions
5.7.4 Aratana Therapeutics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.7.5 Aratana Therapeutics Recent Developments
5.8 ARKO Labs
5.8.1 ARKO Labs Profile
5.8.2 ARKO Labs Main Business
5.8.3 ARKO Labs Veterinary Vaccines Products, Services and Solutions
5.8.4 ARKO Labs Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.8.5 ARKO Labs Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Veterinary Vaccines Products, Services and Solutions
5.9.4 Bayer Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 CanFel Therapeutics
5.10.1 CanFel Therapeutics Profile
5.10.2 CanFel Therapeutics Main Business
5.10.3 CanFel Therapeutics Veterinary Vaccines Products, Services and Solutions
5.10.4 CanFel Therapeutics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.10.5 CanFel Therapeutics Recent Developments
5.11 Ceva Animal Health
5.11.1 Ceva Animal Health Profile
5.11.2 Ceva Animal Health Main Business
5.11.3 Ceva Animal Health Veterinary Vaccines Products, Services and Solutions
5.11.4 Ceva Animal Health Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.11.5 Ceva Animal Health Recent Developments
5.12 Colorado Serum
5.12.1 Colorado Serum Profile
5.12.2 Colorado Serum Main Business
5.12.3 Colorado Serum Veterinary Vaccines Products, Services and Solutions
5.12.4 Colorado Serum Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.12.5 Colorado Serum Recent Developments
5.13 Epitopix
5.13.1 Epitopix Profile
5.13.2 Epitopix Main Business
5.13.3 Epitopix Veterinary Vaccines Products, Services and Solutions
5.13.4 Epitopix Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.13.5 Epitopix Recent Developments
5.14 Genus
5.14.1 Genus Profile
5.14.2 Genus Main Business
5.14.3 Genus Veterinary Vaccines Products, Services and Solutions
5.14.4 Genus Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.14.5 Genus Recent Developments
5.15 Hygieia Biological Laboratories
5.15.1 Hygieia Biological Laboratories Profile
5.15.2 Hygieia Biological Laboratories Main Business
5.15.3 Hygieia Biological Laboratories Veterinary Vaccines Products, Services and Solutions
5.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.15.5 Hygieia Biological Laboratories Recent Developments
5.16 ImmuCell
5.16.1 ImmuCell Profile
5.16.2 ImmuCell Main Business
5.16.3 ImmuCell Veterinary Vaccines Products, Services and Solutions
5.16.4 ImmuCell Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.16.5 ImmuCell Recent Developments
5.17 Nexvet
5.17.1 Nexvet Profile
5.17.2 Nexvet Main Business
5.17.3 Nexvet Veterinary Vaccines Products, Services and Solutions
5.17.4 Nexvet Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.17.5 Nexvet Recent Developments
5.18 Nuovo Biologics
5.18.1 Nuovo Biologics Profile
5.18.2 Nuovo Biologics Main Business
5.18.3 Nuovo Biologics Veterinary Vaccines Products, Services and Solutions
5.18.4 Nuovo Biologics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.18.5 Nuovo Biologics Recent Developments
5.19 UBI
5.19.1 UBI Profile
5.19.2 UBI Main Business
5.19.3 UBI Veterinary Vaccines Products, Services and Solutions
5.19.4 UBI Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.19.5 UBI Recent Developments
5.20 Valneva
5.20.1 Valneva Profile
5.20.2 Valneva Main Business
5.20.3 Valneva Veterinary Vaccines Products, Services and Solutions
5.20.4 Valneva Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.20.5 Valneva Recent Developments
5.21 Vetoquinol
5.21.1 Vetoquinol Profile
5.21.2 Vetoquinol Main Business
5.21.3 Vetoquinol Veterinary Vaccines Products, Services and Solutions
5.21.4 Vetoquinol Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.21.5 Vetoquinol Recent Developments
5.22 Virbac
5.22.1 Virbac Profile
5.22.2 Virbac Main Business
5.22.3 Virbac Veterinary Vaccines Products, Services and Solutions
5.22.4 Virbac Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.22.5 Virbac Recent Developments
6 North America
6.1 North America Veterinary Vaccines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Vaccines Market Dynamics
11.1 Veterinary Vaccines Industry Trends
11.2 Veterinary Vaccines Market Drivers
11.3 Veterinary Vaccines Market Challenges
11.4 Veterinary Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
